We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$37.1M
Cap. Flow
-$48M
Cap. Flow %
-20.83%
Top 10 Hldgs %
50.4%
Holding
85
New
16
Increased
17
Reduced
31
Closed
20

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$7.59M
2
MRK icon
Merck
MRK
+$5.05M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$3.65M
4
BAX icon
Baxter International
BAX
+$3.3M
5
IQV icon
IQVIA
IQV
+$3.29M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$9.5M
2
BDX icon
Becton Dickinson
BDX
+$7.34M
3
JNJ icon
Johnson & Johnson
JNJ
+$6.92M
4
UNH icon
UnitedHealth
UNH
+$6.85M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$6.34M

Sector Composition

Rank Sector Weight
1 Healthcare 93.59%
2 Financials 2.32%
3 Real Estate 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$19.2M 8.32%
115,072
+12,681
+12% +$2.04M
MRK icon
2
Merck
MRK
$322B
$15.7M 6.79%
270,461
+89,471
+49% +$5.05M
ABT icon
3
Abbott
ABT
$183B
$15.6M 6.77%
255,807
-20,925
-8% -$1.27M
SHPG
4
DELISTED
Shire pic
SHPG
$11.5M 4.97%
67,893
+13,897
+26% +$2.24M
CI icon
5
Cigna
CI
$73.7B
$11M 4.75%
64,461
+43,861
+213% +$7.59M
MDT icon
6
Medtronic
MDT
$109B
$10.7M 4.63%
124,724
-10,391
-8% -$868K
DVA icon
7
DaVita
DVA
$15.4B
$9.63M 4.18%
138,676
-2,660
-2% -$178K
ELV icon
8
Elevance Health
ELV
$81.5B
$8.79M 3.81%
36,936
-7,169
-16% -$1.66M
UHS icon
9
Universal Health Services
UHS
$10.2B
$7.16M 3.1%
64,241
-19,159
-23% -$2.24M
JNJ icon
10
Johnson & Johnson
JNJ
$618B
$7.11M 3.08%
58,627
-55,484
-49% -$6.92M
CVS icon
11
CVS Health
CVS
$133B
$6.89M 2.99%
107,073
+2,962
+3% +$195K
VTRS icon
12
Viatris
VTRS
$20.4B
$6.48M 2.81%
179,275
+22,788
+15% +$894K
BAX icon
13
Baxter International
BAX
$13.5B
$5.92M 2.57%
80,229
+46,880
+141% +$3.3M
GILD icon
14
Gilead Sciences
GILD
$162B
$5.87M 2.55%
82,863
+35,663
+76% +$2.52M
CELG
15
DELISTED
Celgene Corp
CELG
$5.66M 2.45%
71,205
+39,205
+123% +$3.26M
TVTY
16
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$5.62M 2.44%
159,692
+98,873
+163% +$3.65M
AET
17
DELISTED
Aetna Inc
AET
$5.36M 2.32%
29,197
+4,885
+20% +$871K
UNH icon
18
UnitedHealth
UNH
$376B
$4.14M 1.79%
16,867
-28,541
-63% -$6.85M
BDX icon
19
Becton Dickinson
BDX
$45.6B
$4.04M 1.75%
17,288
-32,968
-66% -$7.34M
HRC
20
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.75M 1.62%
42,877
+18,477
+76% +$1.64M
HOLX
21
DELISTED
Hologic
HOLX
$3.33M 1.44%
83,656
-87,288
-51% -$3.36M
IQV icon
22
IQVIA
IQV
$38.7B
$3.29M 1.43%
+32,945
New +$3.29M
HCA icon
23
HCA Healthcare
HCA
$87.2B
$3.15M 1.37%
30,755
-14,045
-31% -$1.42M
WMGI
24
DELISTED
Wright Medical Group Inc
WMGI
$2.81M 1.22%
108,258
-4,814
-4% -$110K
ZBH icon
25
Zimmer Biomet
ZBH
$18.2B
$2.5M 1.09%
+23,131
New +$2.52M
1
2 3 4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Endurant Capital Management held 85 positions worth $231M, down 14% from $268M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Endurant Capital Management withdrew a net $48M in Q2 2018, closing 20 positions and reducing 31 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $3.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 93% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Endurant Capital Management opened a new position in IQVIA worth $3.29M.

  • Endurant Capital Management's largest Q2 2018 buy was IQVIA: 32,945 shares worth $3.29M.
  • Endurant Capital Management added most to Cigna in Q2 2018, an estimated $7.59M increase.
  • Endurant Capital Management's biggest Q2 2018 reduction was Boston Scientific, cutting an estimated $9.5M.
  • Endurant Capital Management fully exited Envision Healthcare Holdings Inc in Q2 2018, selling an estimated $3.16M.
  • Endurant Capital Management's ten largest holdings make up 50% of its $231M portfolio in Q2 2018.
  • Endurant Capital Management opened 16 new positions and closed 20 in Q2 2018.
  • Endurant Capital Management's portfolio value fell 14% quarter-over-quarter to $231M.

Based on Endurant Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.